We would like to thank the 160,000+ people from over 50 countries who took part in GDS2018 which was translated into 20 languages.
Across Europe, Scandinavia, North and South America, Australasia, the Balkans and the Middle East people gave of their time so generously. How much time did these amazing people spend making GDS2018 the largest drug survey ever conducted?
about 80,000 hours or
about 3,300 days or
about 475 weeks or
about 100 months
or more than 9 years
All we can say is thank you so much to everyone of them and all our media partners and our international collaborators. GDS would not exist with them and you.
We will start analysing the data and preparing reports next week. We expect the global media release of our GDS2018 Key Findings Report to be released in May 2018. As soon as we have a fixed launch date we will let you know.
Have a safe, healthy and happy 2018.
Professor Adam R Winstock on behalf of The Global Drug Survey Core Research Team
Each year, GDS consults more than 100,000 people around the world on the way they use drugs. We do this to get to the heart of how, where, when, why and what drugs are being taken. By discussing the findings we aim to make drug use safer, regardless of the legal status of the drug.
Share your story with us and help change the conversation. Because your experience matters.
GDS2018 – exploring losing your drug virginity, drug checking, dark net markets, new drugs, quitting cannabis, alcohol health warning labels, drug purchase, delivery and sharing, MDMA – pills or powders and what the perfect MDMA might look like, ketamine bladder GHB and lots more . . .Launch GDS2018 2017 Findings
GDS 2017 — Key findings! 2017 Global Drug Survey shows UK drug purity leading to spike in A&E admissions
GDS is an efficient approach to gain content rich data that explores diverse health outcomes associated with the use of drugs and alcohol across the population of your country.
GDS can help you add numbers and depth to the findings of more rigorous, though less detailed and smaller, survey findings. Using anonymous on-line research tools, designed and analysed by leading experts in the fields of epidemiology, addiction, criminology, toxicology and sociology GDS has access to drug use data from over 500,000 people from over 50 countries.
The GDS sampling frame allows you to effectively compare population segments - young, old, males, females, gay, straight, clubbers, thin people, obese people, vegetarians, those with a current psychiatric symptoms and diagnoses, students, northerners, southerners. GDS helps you better understand the quantitative dynamics of personal decision-making about drug use, detects regional differences in patterns of drug use and related harm, and informs novel interventions.
GDS creates beautiful data reports, digital health assessment tools and free harm reduction resources that aim to make drug use safer regardless of the legal status of the drug GDS reaches hidden, sentinel and hard to reach populations and puts you on top of emerging drug trends in your country and major cities.
RT @RRFdrugreporter: Our interview with Ina Spinnangr about #decriminalization in #Norway: https://t.co/bHJRy7i0YP https://t.co/DXlzrSd17ZOpen
RT @SSA_Addiction: Project NEPTUNE free E-Learning Modules launched today #NPS #clubdrugs https://t.co/MNbcM8mwC3Open
RT @ZachWritesStuff: Hi @NewYorker, there is no such thing as an “opioid addicted baby.” Babies are born dependent, not addicted. The diffe…Open